The Extracellular Bone Marrow Microenvironment-A Proteomic Comparison of Constitutive Protein Release by In Vitro Cultured Osteoblasts and Mesenchymal Stem Cells.

bone marrow cancer conditioned medium exosome extracellular matrix mesenchymal stem cells osteoblasts protein proteomics

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
28 Dec 2020
Historique:
received: 30 11 2020
revised: 22 12 2020
accepted: 23 12 2020
entrez: 31 12 2020
pubmed: 1 1 2021
medline: 1 1 2021
Statut: epublish

Résumé

Mesenchymal stem cells (MSCs) and osteoblasts are bone marrow stromal cells that contribute to the formation of stem cell niches and support normal hematopoiesis, leukemogenesis and development of metastases from distant cancers. This support is mediated through cell-cell contact, release of soluble mediators and formation of extracellular matrix. By using a proteomic approach, we characterized the protein release by in vitro cultured human MSCs (10 donors) and osteoblasts (nine donors). We identified 1379 molecules released by these cells, including 340 proteins belonging to the GO-term Extracellular matrix. Both cell types released a wide range of functionally heterogeneous proteins including extracellular matrix molecules (especially collagens), several enzymes and especially proteases, cytokines and soluble adhesion molecules, but also several intracellular molecules including chaperones, cytoplasmic mediators, histones and non-histone nuclear molecules. The levels of most proteins did not differ between MSCs and osteoblasts, but 82 proteins were more abundant for MSC (especially extracellular matrix proteins and proteases) and 36 proteins more abundant for osteoblasts. Finally, a large number of exosomal proteins were identified. To conclude, MSCs and osteoblasts show extracellular release of a wide range of functionally diverse proteins, including several extracellular matrix molecules known to support cancer progression (e.g., metastases from distant tumors, increased relapse risk for hematological malignancies), and the large number of identified exosomal proteins suggests that exocytosis is an important mechanism of protein release.

Identifiants

pubmed: 33379263
pii: cancers13010062
doi: 10.3390/cancers13010062
pmc: PMC7795818
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Kreftforeningen
ID : 100933

Références

Sci Rep. 2019 Dec 19;9(1):19455
pubmed: 31857649
Nat Methods. 2012 Mar 18;9(5):471-2
pubmed: 22426491
BBA Clin. 2017 Mar 08;7:105-114
pubmed: 28331812
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Clin Chem Lab Med. 2017 Jan 1;55(1):123-131
pubmed: 27305704
Eur J Haematol. 2005 Jan;74(1):24-34
pubmed: 15613103
Expert Opin Ther Targets. 2017 Apr;21(4):357-369
pubmed: 28281897
Stem Cells. 2015 Sep;33(9):2798-810
pubmed: 26013602
Semin Cell Dev Biol. 2009 Apr;20(2):126-37
pubmed: 19049889
Aging Dis. 2019 Feb 01;10(1):174-189
pubmed: 30705777
Stem Cells Int. 2018 Apr 3;2018:1540148
pubmed: 29765406
Cancer Metastasis Rev. 2010 Jun;29(2):249-61
pubmed: 20411303
J Cell Biochem. 2017 Aug;118(8):1984-1993
pubmed: 28112429
Biochem Soc Trans. 2018 Aug 20;46(4):843-853
pubmed: 29986939
Top Curr Chem. 2013;328:241-68
pubmed: 22076079
Cancers (Basel). 2018 Jun 04;10(6):
pubmed: 29867053
Leukemia. 2018 May;32(5):1180-1188
pubmed: 29479064
Bone. 2015 Jan;70:37-47
pubmed: 25445445
PLoS Comput Biol. 2013;9(3):e1002975
pubmed: 23555212
Biochim Biophys Acta. 2012 Nov;1823(11):2087-93
pubmed: 22728331
Front Oncol. 2020 Feb 07;9:1567
pubmed: 32117788
Nat Rev Urol. 2019 Jun;16(6):363-375
pubmed: 30923338
Am J Hematol. 2018 Mar;93(3):430-441
pubmed: 29247535
J Biomed Sci. 2018 Jan 19;25(1):5
pubmed: 29351753
Stem Cells. 2017 Apr;35(4):851-858
pubmed: 28294454
Oncogene. 2016 Aug 4;35(31):4132-40
pubmed: 26592446
J Mol Med (Berl). 2015 Nov;93(11):1203-12
pubmed: 26275789
Cells. 2019 May 16;8(5):
pubmed: 31100966
Cancers (Basel). 2020 Sep 09;12(9):
pubmed: 32916840
Hematology. 2018 Jul;23(6):337-345
pubmed: 29140182
J Immunol. 2015 Jan 15;194(2):491-7
pubmed: 25556251
Leuk Lymphoma. 1996 Nov;23(5-6):423-30
pubmed: 9031071
Curr Med Chem. 2010;17(36):4448-61
pubmed: 21062258
Stem Cells. 2015 Apr;33(4):1359-65
pubmed: 25537496
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Molecules. 2016 Nov 11;21(11):
pubmed: 27845732
N Engl J Med. 2008 Nov 27;359(22):2313-23
pubmed: 19038878
Clin Exp Immunol. 2000 Apr;120(1):22-9
pubmed: 10759759
Br J Haematol. 1995 Oct;91(2):394-402
pubmed: 8547081
Front Immunol. 2017 Feb 09;8:106
pubmed: 28232835
Clin Chim Acta. 2020 Aug;507:75-87
pubmed: 32305537
Am J Hematol. 2013 Sep;88(9):798-802
pubmed: 23695956
Front Immunol. 2017 Jun 08;8:667
pubmed: 28642760
Stem Cell Res. 2015 Nov;15(3):530-541
pubmed: 26468600
Stem Cell Rev Rep. 2014 Feb;10(1):69-78
pubmed: 24052411
Cancer Med. 2014 Apr;3(2):265-72
pubmed: 24519883
Cancer Res. 1993 Jul 15;53(14):3386-93
pubmed: 8324749
J Histotechnol. 2019 Dec;42(4):226-239
pubmed: 31432761
Curr Top Dev Biol. 2016;118:21-44
pubmed: 27137653
J Pathol. 2008 Feb;214(3):357-67
pubmed: 18044827
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Semin Immunol. 2018 Feb;35:69-79
pubmed: 29289420
Haematologica. 2004 Apr;89(4):391-402
pubmed: 15075072
BMC Cell Biol. 2014 Nov 25;15:42
pubmed: 25420887
BMC Cancer. 2014 Jul 18;14:518
pubmed: 25037231
Cell Adh Migr. 2014;8(6):563-77
pubmed: 25482635
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a004978
pubmed: 21421911
Leuk Res. 2005 Feb;29(2):185-96
pubmed: 15607368
Trends Immunol. 2019 Nov;40(11):1053-1070
pubmed: 31645297
Thromb Haemost. 2018 Jul;118(7):1167-1175
pubmed: 29874690
Cancer Immunol Immunother. 2017 Aug;66(8):1059-1067
pubmed: 28501940
Oncotarget. 2013 Jun;4(6):830-43
pubmed: 23919981
Cancers (Basel). 2019 Jul 11;11(7):
pubmed: 31336716
Biochim Biophys Acta Proteins Proteom. 2019 Apr;1867(4):434-441
pubmed: 30716505
Immunity. 2015 Jun 16;42(6):991-1004
pubmed: 26084020
J Cancer Res Clin Oncol. 2005 Jun;131(6):377-84
pubmed: 15776274
J Cell Physiol. 2010 Feb;222(2):268-77
pubmed: 19847802
Int J Biochem Cell Biol. 2010 Nov;42(11):1823-30
pubmed: 20691278
Exp Mol Med. 2017 Jun 16;49(6):e346
pubmed: 28620221
Joint Bone Spine. 2017 Dec;84(6):677-684
pubmed: 28499894
Am J Hematol. 1989 Jun;31(2):142-3
pubmed: 2472059
Blood. 2014 Sep 4;124(10):1645-54
pubmed: 25006128
Haematologica. 2018 Sep;103(9):1462-1471
pubmed: 29773599
J Proteome Res. 2011 Feb 4;10(2):913-20
pubmed: 21067241
Clin Cancer Res. 2014 Feb 1;20(3):711-23
pubmed: 24218511
Int J Cancer. 2004 Oct 10;111(6):858-67
pubmed: 15300797
J Exp Med. 2011 Mar 14;208(3):421-8
pubmed: 21402747
Biomark Res. 2020 Jun 12;8:20
pubmed: 32537166
Stem Cells. 2015 Jul;33(7):2182-95
pubmed: 25825864
Clin Cancer Res. 2008 Sep 1;14(17):5555-64
pubmed: 18765548
Biomaterials. 2019 May;203:96-110
pubmed: 29980291
Genomics Proteomics Bioinformatics. 2015 Feb;13(1):17-24
pubmed: 25724326
Annu Rev Biochem. 2019 Jun 20;88:487-514
pubmed: 31220978
Leuk Lymphoma. 2017 Jun;58(6):1494-1497
pubmed: 27739925
Biochem Biophys Res Commun. 2018 Jan 1;495(1):740-748
pubmed: 29137982
PLoS One. 2013;8(2):e56761
pubmed: 23441215
Biofactors. 2019 Jul;45(4):556-562
pubmed: 31026383
Front Bioeng Biotechnol. 2019 Jun 26;7:154
pubmed: 31297369
Cell Death Dis. 2017 May 25;8(5):e2812
pubmed: 28542146
Nat Protoc. 2009;4(5):698-705
pubmed: 19373234
Expert Opin Ther Targets. 2018 Mar;22(3):263-277
pubmed: 29447008
Int J Mol Sci. 2018 Nov 01;19(11):
pubmed: 30388869
Stem Cells. 2016 Mar;34(3):601-13
pubmed: 26782178
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
World J Stem Cells. 2019 Jun 26;11(6):337-346
pubmed: 31293716
Nat Methods. 2015 Nov;12(11):1003-4
pubmed: 26513550
J Clin Med. 2019 Jul 04;8(7):
pubmed: 31277464
Cell Biol Int. 2016 Jun;40(6):671-85
pubmed: 27005844
Ann N Y Acad Sci. 2016 Apr;1370(1):5-14
pubmed: 26663266
Int J Biol Sci. 2017 Sep 5;13(9):1109-1117
pubmed: 29104502
PLoS One. 2015 Oct 29;10(10):e0141331
pubmed: 26513261
J Cancer Res Clin Oncol. 2017 Oct;143(10):1985-1998
pubmed: 28631213
Eur J Haematol. 2003 Sep;71(3):163-73
pubmed: 12930316
J Endod. 2018 Nov;44(11):1686-1691
pubmed: 30217466
Biochimie. 2013 Dec;95(12):2196-211
pubmed: 23880644
Haematologica. 2018 May;103(5):810-821
pubmed: 29545342

Auteurs

Elise Aasebø (E)

Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.

Even Birkeland (E)

The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, N-5021 Bergen, Norway.

Frode Selheim (F)

The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, N-5021 Bergen, Norway.

Frode Berven (F)

The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, N-5021 Bergen, Norway.

Annette K Brenner (AK)

Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.

Øystein Bruserud (Ø)

Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway.
Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway.

Classifications MeSH